Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02786420 · ClinicalTrials.gov registry record
Imaging Innovations for Placental Assessment in Response to Environmental Pollution (PARENTs)
A clinical trial, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- 199
- Enrollment target
NCT02786420: Completed study, sponsored by University of California, Los Angeles.
NCT02786420 is a clinical trial that has completed, run by University of California, Los Angeles. The registered enrollment target is 199 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02786420 has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- 199 participants
- Enrollment target
Study Summary
How environmental pollution contributes to poor pregnancy outcome is poorly understood. The first trimester of pregnancy is a particularly vulnerable time period for the developing fetus and a mother's exposure to air pollution may alter the way that the placenta is established and how it functions throughout the rest of pregnancy. This project aims to expand and develop new MRI technologies to assess real-time placental structure and function as pregnancy develops from the first to the third trimester so that early detection, prevention strategies, and early treatment of placental dysfunction as a result of pollution exposures may be developed.
Primary Outcome
To use multi-parametric MRI technology to assess the impact of environment pollution exposure on prediction of placental insufficiency and related outcomes (pre-eclampsia, preterm birth, and IUGR)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 199 participants |
| Start Date | 2015-10-02 |
| Est. Completion | 2020-10-03 |
What the finished NCT02786420 record still lists
NCT02786420 is an observational study that tracks outcomes without assigning an intervention. The registered 199 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02786420 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02786420 about?
NCT02786420 is a clinical study titled "Imaging Innovations for Placental Assessment in Response to Environmental Pollution (PARENTs)". How environmental pollution contributes to poor pregnancy outcome is poorly understood. The first trimester of pregnancy is a particularly vulnerable time period for the developing fetus and a mother's exposure to air pollution may alter the way that the placenta is established and how it functions ...
What is the current status of trial NCT02786420?
This trial is currently completed. The enrollment target is 199 participants. The study started on 2015-10-02. Estimated completion is 2020-10-03.
Who is sponsoring clinical trial NCT02786420?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04312126 · 199 participants
The Beneficial Effects of Naps on Motor Learning
- NCT04951622 · 199 participants · Phase 3
A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
- NCT06474533 · 199 participants
Fluoroethyltyrosine for the Evaluation of Intracranial Neoplasm
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI